Our findings indicate that intestinal‐type GC in PRH aligns with the CIN molecular classification, showing a higher frequency of TP53 mutations (88.9% vs. 47.5% in TCGA). This evidence concerns the gene TP53 and cervical squamous intraepithelial neoplasia.